Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FirstPoint Biotech Inc.

Latest From FirstPoint Biotech Inc.

People Power: How The Crowd May Shape The Funding And Development Of Drugs

Companies are sprouting across the pharma value chain that harness the voices of patients and other individual stakeholders to drive the research, development, and financing of drugs. Pharma is taking tentative steps toward using these methods, but high barriers remain to their systematic integration in R&D.

BioPharmaceutical Innovation

Demand for non-clinical development support drives L2D expansion

An increase in demand from small- and medium-sized drug development companies for non-clinical development support has led to one young CRO, Leads to Development (L2D), opening new two new offices alongside its Paris, France base.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • FirstPoint Biotech Inc.
  • Senior Management
  • Contact Info
  • FirstPoint Biotech Inc.
    Phone: (415) 835-1310
    One Embarcadero Ctr., Ste. 500
    San Francisco, CA 94111